Vaccines
As US vaccination rates have been hovering in the 50% of the population range for two months, President Biden hit the old dusty trail to push his vaccine mandate even more.
GlaxoSmithKline shares jumped in aftermarket trading Wednesday after the WHO recommended broad deployment of the company’s malaria vaccine in sub-Saharan Africa and other areas.
Here’s a look at mRNA vaccines and their effectiveness and more COVID-19 news.
Pfizer’s exec team is hit with a double whammy as another c-suite leader announces his retirement.
The question is continually being raised: what offers superior protection, a vaccine against COVID-19 or natural immunity?
The patch is not only painless, it requires less vaccine to generate the same or greater effects.
Moderna seeks to invalidate two patents of Arbutus Biopharma Corp. The company hopes to appeal a preemptive challenge to the patents upheld by the U.S. Patent Trial and Appeals Board.
Data from the Phase II CYPRESS study presented at the virtual IDWeek (Infectious Disease Week) 2021 showed that the vaccine candidate provided a robust response against the infection.
Scientists are making progress toward a vaccine that could help protect against deadly overdoses.
First COVID-19, now cancer. BioNTech made history when its COVID-19 mRNA vaccine with partner Pfizer became the first ever approved.
PRESS RELEASES